LYTRALON Trademark

Trademark Overview

On Thursday, May 28, 2015, a trademark application was filed for LYTRALON with the United States Patent and Trademark Office. The USPTO has given the LYTRALON trademark a serial number of 86644199. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2017. This trademark is owned by Pfizer Inc.. The LYTRALON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
lytralon

General Information

Serial Number86644199
Word MarkLYTRALON
Filing DateThursday, May 28, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain
Translation of Words in MarkThe wording "LYTRALON" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 3, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, August 28, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 28, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2017EXTENSION 2 GRANTED
Tuesday, January 10, 2017EXTENSION 2 FILED
Tuesday, January 10, 2017TEAS EXTENSION RECEIVED
Thursday, June 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 28, 2016EXTENSION 1 GRANTED
Tuesday, June 28, 2016EXTENSION 1 FILED
Tuesday, June 28, 2016TEAS EXTENSION RECEIVED
Tuesday, January 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 26, 2015ASSIGNED TO LIE
Saturday, October 17, 2015ASSIGNED TO LIE
Wednesday, September 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, September 16, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 16, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, September 16, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 2, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 2, 2015NON-FINAL ACTION WRITTEN
Friday, August 28, 2015ASSIGNED TO EXAMINER
Wednesday, June 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 1, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

lytralon pain treatment preparations pharmaceutical